Progress and promise of CAR-T cell treatment in autoimmune diseases

Bachl J, Hagen M, Schett G (2026)

Publication Type: Journal article

Publication year: 2026

Journal

Plos Medicine Public Library of Science

Book Volume: 23

Article Number: e1005179

Journal Issue: 7

DOI: 10.1371/journal.pmed.1005179

Abstract

Chimeric antigen receptor (CAR)-expressing cells bear a great potential for the treatment of autoimmune diseases. While numerous challenges persist, recent technological developments have demonstrated the potential for CAR cells to reset dysfunctional immune systems and transform care for patients with autoimmune disease.

Authors with CRIS profile

Jule Bachl Department of Medicine 3 – Rheumatology and Immunology Melanie Hagen Department of Medicine 3 – Rheumatology and Immunology Georg Schett Lehrstuhl für Innere Medizin III

How to cite

APA:

Bachl, J., Hagen, M., & Schett, G. (2026). Progress and promise of CAR-T cell treatment in autoimmune diseases. Plos Medicine, 23(7). https://doi.org/10.1371/journal.pmed.1005179

MLA:

Bachl, Jule, Melanie Hagen, and Georg Schett. "Progress and promise of CAR-T cell treatment in autoimmune diseases." Plos Medicine 23.7 (2026).

BibTeX: Download